U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H32O7
Molecular Weight 432.5067
Optical Activity UNSPECIFIED
Additional Stereochemistry Yes
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0
Stereo Comments AXIAL, R

SHOW SMILES / InChI
Structure of SCHISANDRIN

SMILES

COC1=CC2=C(C(OC)=C1OC)C3=C(OC)C(OC)=C(OC)C=C3C[C@](C)(O)[C@@H](C)C2

InChI

InChIKey=YEFOAORQXAOVJQ-RZFZLAGVSA-N
InChI=1S/C24H32O7/c1-13-9-14-10-16(26-3)20(28-5)22(30-7)18(14)19-15(12-24(13,2)25)11-17(27-4)21(29-6)23(19)31-8/h10-11,13,25H,9,12H2,1-8H3/t13-,24-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H32O7
Molecular Weight 432.5067
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Schisandrin is a bioactive compound found in Schisandra chinensis. Schisandrin exhibits antioxidant properties and ameliorates ovariectomy-induced memory impairment in rats, and Aβ1-42-induced memory impairment in mice. Schisandrin has an anti-asthmatic effect on OVA-induced airway inflammation in a murine asthma model. The compound inhibits proliferation of breast cancer cell lines at concentrations of 20-100 uM.

CNS Activity

Curator's Comment: Ameliorates memory impairment in rats and mice

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P25105
Gene ID: 5724.0
Gene Symbol: PTAFR
Target Organism: Homo sapiens (Human)
250.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties.
2015-05
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
2015-04-25
Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
2010-11
Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells.
2010-02
Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists.
1999-03
Bioactivity of neolignans from fructus Schizandrae.
1991
Patents

Patents

Sample Use Guides

In a study of cognitive dysfunction in ovariectomized rats schizandrin was administered orally at 10 and 30 mg/kg
Route of Administration: Oral
Effect of schisandrin on proliferation of breast cancer cell lines was determined with the sulforhodamine B protein staining method. T47D and MDA-MB-213 cells were treated with 0.8 - 100 uM of schisandrin for 3 days.
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:39:29 GMT 2025
Edited
by admin
on Mon Mar 31 23:39:29 GMT 2025
Record UNII
G01BQC0879
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SCHISANDRIN
INCI   USP-RS  
INCI  
Official Name English
(+)-SCHIZANDRIN
Preferred Name English
7ALPHA-HYDROXYSCHIZANDRONOL
Common Name English
SCHISANDRINE
Common Name English
WUWEIZICHUN A
Common Name English
SCHIZANDRINE
Common Name English
SCHISANDRIN (SCHISANDROL A) (CONSTITUENT OF NORTHERN SCHISANDRA) [DSC]
Common Name English
DIBENZO(A,C)CYCLOOCTEN-6-OL, 5,6,7,8-TETRAHYDRO-1,2,3,10,11,12-HEXAMETHOXY-6,7-DIMETHYL-, (6S,7S,12AR)-
Systematic Name English
SCHISANDRIN [USP-RS]
Common Name English
WUWEIZI ALCOHOL A
Common Name English
SCHIZANDROL
Common Name English
SCHIZANDRIN
Common Name English
Code System Code Type Description
FDA UNII
G01BQC0879
Created by admin on Mon Mar 31 23:39:29 GMT 2025 , Edited by admin on Mon Mar 31 23:39:29 GMT 2025
PRIMARY
PUBCHEM
3001664
Created by admin on Mon Mar 31 23:39:29 GMT 2025 , Edited by admin on Mon Mar 31 23:39:29 GMT 2025
PRIMARY
RS_ITEM_NUM
1609895
Created by admin on Mon Mar 31 23:39:29 GMT 2025 , Edited by admin on Mon Mar 31 23:39:29 GMT 2025
PRIMARY
CAS
7432-28-2
Created by admin on Mon Mar 31 23:39:29 GMT 2025 , Edited by admin on Mon Mar 31 23:39:29 GMT 2025
PRIMARY
EPA CompTox
DTXSID20995843
Created by admin on Mon Mar 31 23:39:29 GMT 2025 , Edited by admin on Mon Mar 31 23:39:29 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT